Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Leontien Kremer

Principal Investigator
Leontien Kremer
Leontien Kremer
--
Phone 088 97 290 000

 --

  • Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines

    • dec. 2022
    • Esmée C., de Baat, et al
    • The Lancet Child and Adolescent Health
  • Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines

    • sep. 2022
    • Esmée C., de Baat, et al
    • Cochrane Database of Systematic Reviews
  • Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors

    • sep. 2022
    • Laura, van Iersel, et al
    • Endocrine reviews
  • Psychosocial developmental milestones of young adult survivors of childhood cancer

    • aug. 2022
    • , et al
    • Supportive Care in Cancer
  • Cardiac function in childhood cancer survivors treated with vincristine

    • aug. 2022
    • , et al
    • International journal of cardiology
View all publications